Fingerprint
Dive into the research topics of 'Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
G. Norman, S. Rice, E. Spackman, L. Stirk, A. Danso-Appiah, D. Suh, S. Palmer, A. Eastwood
Research output: Contribution to journal › Review article › peer-review
14
Citations
(Scopus)